Trial ID 20289 | Maryland Oncology Hematology Trial ID 20289 – Maryland Oncology Hematology

Trial ID 20289

Trial Information - Phase I

A Phase 1 Study of SEA-TGT (SGN-TGT) in Subjects with Advanced Malignancies

Protocol ID: SGNTGT-001

Sponsor: Seagen, Inc.

Status: OPEN TO ENROLLMENT

Contact us regarding Clinical Trials at MOHRSCH@usoncology.com
or call us at 877-664-7724

Disease Types

Head and Neck

Investigator

Wallmark MD, John

Status

OPEN TO ENROLLMENT

Sponsor

Seagen, Inc.

Quality Care Close to Home


View our locations on map!

Sign Up Today For Our E-Newsletter

  • This field is for validation purposes and should be left unchanged.
United in Healing with The US Oncology Network - Maryland Oncology Hematology